Published in Hepatitis Weekly, April 15th, 2002
One way to do this may be to prescribe for them peginterferon, which according to some studies has been more effective than standard interferon (IFN)-alfa for improving viral response in hepatitis C virus (HCV)-positive patients.
In a study supported by Hoffmann-La Roche, David Bernstein, North Shore University Hospital, Manhasset, New York, collaborated with personnel at other centers to assess quality of life and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.